Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enhanced community case management for childhood pneumonia
ACTRN12617000857303Phase 4Recruiting
- Sponsor
- World Health Organization
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 4, randomised, open-label trial of amoxicillin in pneumonia and acute respiratory illness (ARI) (2 arms), sponsored by World Health Organization. Primary endpoint: Treatment failure rate within day 1-6. Started Sep 2016; status: recruiting.
02
Drugs
amoxicillin
03
Conditions
pneumoniaacute respiratory illness (ARI)
Beyond the preview
Go deeper on ACTRN12617000857303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000857303.